Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMMEDIATE: GIK in Acute Coronary Syndromes
NCT00091507Phase 3Completed
- Sponsor
- Tufts Medical Center
- Start
- Nov 2006
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glucose-insulin-potassium in acute coronary syndrome (ACS), sponsored by Tufts Medical Center. Started Nov 2006; status: completed.
02
Drugs
glucose-insulin-potassium
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00091507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091507.